Navigation Links
Medasense Receives Patent Approval for Novel Pain-Monitoring System
Date:8/20/2013

Tel Aviv, Israel (PRWEB) August 20, 2013

Medasense Biometrics Ltd. announced today it has received U.S. patent approval for its novel system and multi-parameter method of assessing the pain level of patients in various states of consciousness. (U.S. Patent No. 8,512,240 – “System and Method for Pain Monitoring Using a Multidimensional Analysis of Physiological Signals.”)

Medasense’s innovative technology enables non-invasive, objective, pain monitoring by measuring multiple pain-related physiological parameters. The data is then integrated using state-of-the-art signal processing and pattern recognition algorithms to identify a patient’s unique “signature of pain.” Using this information, physicians can adapt pain medications to patient-specific needs to reduce suffering and improve treatment outcomes.

“Pain is now widely considered the fifth vital sign,” says Galit Zuckerman, founder and CEO of Medasense. “Our easy-to-use system adds objective pain measurement to the array of technically advanced patient-monitoring tools already used in critical care, anesthesia and recovery, and similar environments.”

Medasense’s successfully completed clinical studies verify the system’s ability to accurately measure pain response and demonstrate that it outperforms all existing pain indicators. “Receiving this patent approval is a milestone achievement for the Medasense team,” says Zuckerman. “We look forward to providing physicians with a much better way to monitor and manage patient pain.”

About Medasense
Medasense Biometrics Ltd. is an early-stage medical device company specializing in innovative pain monitoring solutions. The company’s automated pain-monitoring system is designed to provide a continuous, highly accurate assessment of a patient’s pain level. Medasense is financed and supported by both private investors and by Medoc Ltd., a prominent manufacturer of pain diagnostic medical systems. For more information, visit: http://www.medasense.com/.

CONTACT:
Nir Ben Israel
Medasense Biometric Ltd.
info(at)medasense(dot)com
Tel. 972-4-9038800

Read the full story at http://www.prweb.com/releases/2013/8/prweb11038757.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. UCSB professor receives award for graphene electronics research
2. Watsons Generic Yaz(R) Receives FDA Approval
3. Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin
4. Life Technologies Ion Personal Genome Machine Receives San Diegos CONNECT Most Innovative New Product Award
5. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
6. Intimate Bridge 2 Conception, Inc. Receives $4.3M
7. Pacific Meso Center Receives Generous Donation to First Free-Standing Mesothelioma Research Laboratory in Los Angeles
8. BioNeutral Group Receives $400,000 in Equity Financing
9. Amsterdam Molecular Therapeutics Receives US Orphan Designation for Hemophilia B Gene Therapy
10. Arcion Receives Notice of Allowance for US Patent for Novel Topical Lidocaine Formulation for Pain
11. Life Technologies Receives AFNOR Validation for Tests Designed to Detect Listeria Contamination in Food Samples
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2019)... ... 17, 2019 , ... Consumers are directing healthcare in many ... That's changing as many services now exist for patients to order tests without ... $208 million in 2018, according to Kalorama Information’s new report, The Direct-To-Consumer ...
(Date:1/20/2019)... ... January 17, 2019 , ... Today, Advanced Solutions, Inc., a ... specialized automation technology, titled Automate 3D. Automate 3D, produced by Advanced Solutions, allows ... to deliver to end-users, customers, and ERP systems. , Automate 3D ...
(Date:1/15/2019)... ... , ... Personalized treatment plans may extend life expectancy for early-stage kidney cancer ... published in the journal Radiology. , Kidney, or renal, tumors are often discovered ... in which the tumor and part of the kidney are removed. However, some patients, ...
(Date:1/11/2019)... ... 2019 , ... Boekel Scientific launches its new Touch Screen ... This advanced and intuitive medical device was designed in conjunction with stationary and ... busiest donor stations with new-to-the industry features to improve efficiency and operational ease. ...
Breaking Biology Technology:
(Date:1/4/2019)... ... January 03, 2019 , ... Stay on top of current hot topics ... industries. Access to all webinars is free, so be sure to register today to ... http://www.xtalks.com to check out our upcoming webinars, or click below to learn ...
(Date:12/25/2018)... ... 2018 , ... Researchers at the Icahn School of Medicine ... a long-standing computational concept known as “blacklisting,” which is commonly employed as a ... as a filter to single out genetic variations in patient genomes and exomes ...
(Date:12/19/2018)... ... December 19, 2018 , ... NDA Partners Chairman Carl Peck, MD, announced ... the FDA Center for Devices and Radiological Health (CDRH), has been appointed a Partner ... since 2015, and she has more than 25 years of regulatory experience. In addition ...
Breaking Biology News(10 mins):